(Q34586801)

English

Evaluation of the safety and efficacy of bremelanotide, a melanocortin receptor agonist, in female subjects with arousal disorder: a double-blind placebo-controlled, fixed dose, randomized study.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18179455%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

retracted paper

1 reference

Retraction Watch

29 December 2023

https://doi.org/10.1111/j.1743-6109.2007.00698.x

http://retractionwatch.com/?s=Mohammad+Reza+Safarinejad

RETRACTED: Evaluation of the safety and efficacy of bremelanotide, a melanocortin receptor agonist, in female subjects with arousal disorder: a double-blind placebo-controlled, fixed dose, randomized study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18179455%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

0 references

Mohammad Reza Safarinejad

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18179455%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Mohammad Reza Safarinejad

1

1 reference

Europe PubMed Central

3 August 2017

publication date

28 December 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18179455%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

number of pages

11

1 reference

based on heuristic

inferred from page(s)

The Journal of Sexual Medicine

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18179455%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18179455%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18179455%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

887-897

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18179455%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Current management strategies of the postmenopausal patient with sexual health problems

1 reference

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2007.00698.X

9 February 2024

Female sexual satisfaction and pharmaceutical intervention: a critical review of the drug intervention studies in female sexual dysfunction

1 reference

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2007.00698.X

9 February 2024

Sexual dysfunction in the United States: prevalence and predictors

1 reference

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2007.00698.X

9 February 2024

An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist

1 reference

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2007.00698.X

9 February 2024

Selective facilitation of sexual solicitation in the female rat by a melanocortin receptor agonist

1 reference

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2007.00698.X

9 February 2024

Modeling response rates in surveys of female sexual difficulty and dysfunction.

1 reference

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2007.00698.X

9 February 2024

Sexual problems among a specific population of minority women aged 40-80 years attending a primary care practice

1 reference

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2007.00698.X

9 February 2024

Clinical practice. Sexual desire and arousal disorders in women

1 reference

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2007.00698.X

9 February 2024

Sexual dysfunctions: classifications and definitions

1 reference

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2007.00698.X

9 February 2024

Effect of an alpha-melanocyte stimulating hormone analog on penile erection and sexual desire in men with organic erectile dysfunction

1 reference

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2007.00698.X

9 February 2024

Female sexual dysfunction in a population-based study in Iran: prevalence and associated risk factors.

1 reference

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2007.00698.X

9 February 2024

Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of subcutaneously administered PT-141, a melanocortin receptor agonist, in healthy male subjects and in patients with an inadequate response to Viagra

1 reference

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2007.00698.X

9 February 2024

The enhancement of vaginal vasocongestion by sildenafil in healthy premenopausal women

1 reference

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2007.00698.X

9 February 2024

Evaluating the impact of overactive bladder on sexual health in women: what is relevant?

1 reference

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2007.00698.X

9 February 2024

Key Methodological Issues in Sexual Medicine Research

1 reference

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2007.00698.X

9 February 2024

Discovery that a melanocortin regulates sexual functions in male and female humans

1 reference

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2007.00698.X

9 February 2024

Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder

1 reference

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2007.00698.X

9 February 2024

PT-141: a melanocortin agonist for the treatment of sexual dysfunction

1 reference

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2007.00698.X

9 February 2024

Prevalence and evaluation of sexual health problems--HSDD in Europe.

1 reference

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2007.00698.X

9 February 2024

Frequency of sexual dysfunction in "normal" couples

1 reference

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2007.00698.X

9 February 2024

Prevalence of sexual dysfunction in women: results of a survey study of 329 women in an outpatient gynecological clinic

1 reference

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2007.00698.X

9 February 2024

Physiology and pathophysiology of female sexual function and dysfunction

1 reference

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2007.00698.X

9 February 2024

Topical alprostadil treatment of female sexual arousal disorder

1 reference

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2007.00698.X

9 February 2024

Women's sexual dysfunction: revised and expanded definitions

1 reference

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2007.00698.X

9 February 2024

The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function

1 reference

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2007.00698.X

9 February 2024

Cues resulting in desire for sexual activity in women

1 reference

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2007.00698.X

9 February 2024

Short-term analysis of the effects of as needed use of sertraline at 5 PM for the treatment of premature ejaculation

1 reference

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2007.00698.X

9 February 2024

Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction

1 reference

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2007.00698.X

9 February 2024

Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind, placebo controlled study

1 reference

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2007.00698.X

9 February 2024

Identifiers

10.1111/J.1743-6109.2007.00698.X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18179455%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18179455%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34586801&oldid=2072914920"